Memorial Cancer Institute

Memorial Regional Hospital

Hollywood, FL

Sorting 1 by

Accepting patients

JSP191 (Briquilimab)

A Phase 1 Open-label, Dose-escalation, Safety, and Tolerability Study of JSP191 as a Second-line Therapy in Subjects With Lower-Risk Myelodysplastic Syndrome (LR-MDS)
Learn more
  • Monoclonal Antibody
  • Phase 1